Evidence map›Paper›PMID 26554750›Full record

ArticlePharmacoepidemiology and drug safety2016

Prenatal triptan exposure and parent-reported early childhood neurodevelopmental outcomes: an application of propensity score calibration to adjust for unmeasured confounding by migraine severity.

Mollie E Wood, Jean A Frazier, Hedvig M E Nordeng, Kate L Lapane

Abstract readValidation Study
In one paragraph

Article in Pharmacoepidemiology and drug safety, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Chronic pain during pregnancy: a review of the literature.International journal of women's health · 2018
    Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Mollie E WoodDepartment of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, USA.
Jean A FrazierDepartment of Psychiatry, University of Massachusetts Medical School, Worcester, MA, USA.
Hedvig M E NordengSchool of Pharmacy, University of Oslo, Oslo, Norway.
Kate L LapaneDepartment of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, USA.
University of Massachusetts Chan Medical School · USDrug Safety Research Unit · GBUniversity of Oslo · NO

Funding

Gene-Environment Interactions in an Autism Birth CohortU01NS047537 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LIPKIN, W. IAN · 2003 to 2013
$27.0M
Exposing the Deep Content of the Publication: Knowledge Extraction for Neuroimaging in Child PsychiatryR01MH083320 · NIMH · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FRAZIER, JEAN A, KENNEDY, DAVID NELSON · 2009 to 2020
$6.3M
SUPPORT SERVICES FOR EPIDEMIOLOGYN01ES085433 · NIEHS · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI TER MAAT, JAMES L · 1998 to 2000
$2.6M
NIEHS NIH HHS N01 ES075558NIEHS NIH HHS N01 ES085433NIMH NIH HHS R01 MH083320NINDS NIH HHS U01 NS047537
6 · The paper itself

Abstract

purposeTriptan medications are serotonin agonists used to treat migraine, a chronic pain condition highly prevalent in women of reproductive age. Data on the safety of triptans during pregnancy are scant. We sought to quantify the association of prenatal triptan exposure on neurodevelopment in 3-year-old children.

methodsUsing data from the Norwegian Mother and Child Cohort Study, we used propensity score matching to examine associations between prenatal triptan exposure and psychomotor function, communication, and temperament. We used an external validation study to perform propensity calibration to adjust effect estimates for confounders unmeasured in the main study (migraine severity, type, and maternal attitudes towards medication use).

resultsWe identified 4204 women who reported migraine headache at baseline, of which 375 (8.9%) reported using a triptan greater than or equal to once during pregnancy. Children with prenatal triptan exposure had 1.37-fold greater unadjusted odds of fine motor problems (95% confidence interval (CI): 1.06-1.77), which decreased after propensity score matching (odds ratio (OR): 1.29, 95%CI 0.97-1.73) and was further attenuated after calibration (OR: 1.25, 95%CI 0.89-1.74). We observed no increased risk for gross motor or communication problems, and no differences in temperament. Adjustment for migraine severity using propensity score calibration had a moderate impact on effect estimates, with percent changes ranging from 2.4% to 50%.

conclusionsPrenatal triptan exposure was not associated with psychomotor function, communication problems, or temperament in 3-year-old children. Adjustment for migraine severity reduced effect estimates and should be considered in future studies of the safety of triptans during pregnancy. Copyright © 2015 John Wiley & Sons, Ltd.

Indexed as

AdultChild, PreschoolChronic DiseaseCohort StudiesConfounding Factors, EpidemiologicFemaleHumansMigraine DisordersNeurodevelopmental DisordersNorwayPregnancyPregnancy ComplicationsPrenatal Exposure Delayed EffectsPropensity ScoreSeverity of Illness IndexTryptaminesTryptamineschild neurodevelopmentmigrainepharmacoepidemiologypregnancy medicationpropensity score calibration

Identifiers

PMID26554750
PMCPMC5071383
OpenAlexW2146355289

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.